V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20162589 | 20062779 | 1.61 | 56.7 | Palliative (P) | 2017-07-18 | 2017-07-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100530613 |
| 20162592 | 20062780 | 1.7 | 60.6 | Neo-adjuvant (N) | 2016-11-03 | 2016-11-17 | ECX | N | N | ECX | 101317568 |
| 20162593 | 20062781 | 1.7 | 78.7 | Palliative (P) | null | 2019-01-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101172062 |
| 20162595 | 20062782 | 1.6 | 55 | Adjuvant (A) | 2016-06-29 | 2016-07-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101732832 |
| 20162597 | 20062783 | 1.63 | 77.5 | Adjuvant (A) | 2019-03-22 | 2019-03-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101013753 |
| 20162605 | 20062784 | 1.58 | 52 | Neo-adjuvant (N) | 2020-01-12 | 2020-01-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100158374 |
| 20162614 | 20062785 | 1.65 | 67.55 | Adjuvant (A) | 2016-01-18 | 2016-02-11 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100956498 |
| 20162616 | 20062786 | 1.71 | 75 | Neo-adjuvant (N) | 2019-01-03 | 2019-01-11 | ECX | 02 | null | ECX | 100464560 |
| 20162617 | 20062787 | 1.72 | 70 | Palliative (P) | 2017-08-29 | 2017-09-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100724316 |
| 20162619 | 20062788 | 1.74 | 64.8 | Adjuvant (A) | 2016-07-10 | 2016-07-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101375691 |
| 20162620 | 20062789 | 1.55 | 86.7 | Palliative (P) | null | 2019-05-17 | ECX | null | N | ECX | 101690385 |
| 20162637 | 20062790 | 1.73 | 62 | Palliative (P) | 2018-08-25 | 2018-09-20 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101546276 |
| 20162638 | 20062791 | null | 123 | Adjuvant (A) | 2017-03-04 | 2017-04-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100068681 |
| 20162639 | 20062792 | 1.78 | 74.8 | Curative (C) | 2018-05-15 | 2018-05-24 | ECX | N | N | ECX | 100949812 |
| 20162640 | 20062793 | 1.48 | 72 | Neo-adjuvant (N) | 2018-03-07 | 2018-03-10 | ECX | 02 | Y | ECX | 100246442 |
| 20162641 | 20062794 | 1.69 | 91 | Adjuvant (A) | 2019-11-19 | 2019-12-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100642174 |
| 20162644 | 20062795 | 1.56 | 76.8 | Palliative (P) | 2019-02-23 | 2019-03-09 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100699530 |
| 20162646 | 20062796 | 1.77 | 52 | Palliative (P) | 2018-01-05 | 2018-01-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100224002 |
| 20162652 | 20062797 | 1.61 | 117 | Adjuvant (A) | 2016-03-16 | 2016-03-17 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 101284272 |
| 20162653 | 20062798 | 1.57 | 50 | Adjuvant (A) | 2019-04-12 | 2019-05-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101003662 |
| 20162660 | 20062799 | 1.65 | 77.2 | Palliative (P) | 2020-01-02 | 2020-01-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100456404 |
| 20162668 | 20062800 | 1.6 | 79.8 | null | 2019-05-28 | 2019-06-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100878644 |
| 20162670 | 20062801 | 1.5 | 79.8 | Palliative (P) | 2016-04-02 | 2016-04-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100825162 |
| 20162671 | 20062802 | 1.56 | 64.9 | Neo-adjuvant (N) | 2016-02-22 | 2016-02-26 | ECX | N | N | ECX | 100376145 |
| 20162673 | 20062803 | 1.77 | 70.5 | null | 2020-01-21 | 2020-01-21 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100675280 |
| 20162675 | 20062804 | 1.58 | 61 | Neo-adjuvant (N) | 2016-12-22 | 2017-01-10 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100138079 |
| 20162677 | 20062805 | 1.78 | 73.9 | Palliative (P) | 2016-11-01 | 2016-11-19 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100480652 |
| 20162680 | 20062806 | 1.8 | 65 | null | 2018-02-26 | 2018-03-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100084829 |
| 20162684 | 20062807 | 1.58 | 77.2 | Palliative (P) | 2016-07-11 | 2016-07-15 | ECX | 02 | N | ECX | 101291671 |
| 20162687 | 20062808 | 1.49 | 54.8 | Palliative (P) | null | 2017-11-11 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100801069 |
| 20162689 | 20062809 | 1.67 | 48.9 | Palliative (P) | 2017-07-20 | 2017-07-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100333798 |
| 20162695 | 20062810 | 1.88 | 80.3 | Neo-adjuvant (N) | 2016-06-13 | 2016-07-04 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101618836 |
| 20162704 | 20062811 | 1.72 | 90 | Neo-adjuvant (N) | 2017-07-25 | 2017-08-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100717312 |
| 20162707 | 20062812 | 1.58 | 127 | Palliative (P) | 2016-06-18 | 2016-06-24 | ECX | N | N | ECX | 101567143 |
| 20162710 | 20062813 | 1.93 | 77.9 | Adjuvant (A) | 2018-10-23 | 2018-11-11 | CAPECITABINE + GEMCITABINE | N | Y | CAPECITABINE + GEMCITABINE | 101394071 |
| 20162713 | 20062814 | 1.61 | 48.7 | Palliative (P) | 2017-06-17 | 2017-06-17 | ECX | 2 | N | ECX | 100268819 |
| 20162717 | 20062815 | null | 86.6 | Curative (C) | 2017-04-14 | 2017-04-14 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101143554 |
| 20162732 | 20062816 | 1.61 | null | Neo-adjuvant (N) | 2016-11-11 | 2016-11-30 | ECX | N | N | ECX | 101859236 |
| 20162733 | 20062817 | 1.62 | 69.2 | Neo-adjuvant (N) | 2017-06-11 | 2017-06-19 | ECX | 2 | N | ECX | 100062718 |
| 20162737 | 20062818 | 1.77 | 91 | null | 2018-06-09 | 2018-06-22 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100971432 |
| 20162738 | 20062819 | 1.86 | 119.7 | Palliative (P) | 2017-02-11 | 2017-02-20 | ECX | N | N | ECX | 101106799 |
| 20162739 | 20062820 | 1.64 | 57.7 | Palliative (P) | 2019-10-05 | 2019-10-05 | ECX | N | N | ECX | 101656808 |
| 20162746 | 20062821 | 1.67 | 70 | Palliative (P) | 2018-09-11 | 2018-09-15 | ECX | 02 | N | ECX | 100606670 |
| 20162748 | 20062822 | 1.73 | 63.6 | Palliative (P) | 2017-12-05 | 2017-12-17 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100056967 |
| 20162750 | 20062823 | 1.7 | 100.7 | Palliative (P) | 2018-10-31 | 2018-11-22 | ECX | N | null | ECX | 100179020 |
| 20162751 | 20062824 | 1.73 | 75 | null | 2017-04-22 | 2017-04-29 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100730483 |
| 20162754 | 20062825 | 1.55 | 80 | Neo-adjuvant (N) | 2018-07-19 | 2018-08-09 | ECX | null | N | ECX | 100230610 |
| 20162757 | 20062826 | null | 57.5 | Neo-adjuvant (N) | 2019-07-24 | 2019-08-09 | ECX | N | N | ECX | 100838797 |
| 20162759 | 20062827 | 1.75 | 110 | Adjuvant (A) | 2018-09-04 | 2018-09-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101315442 |
| 20162770 | 20062828 | 1.64 | 100.8 | Neo-adjuvant (N) | 2018-03-05 | 2018-03-22 | ECX | N | N | ECX | 100247078 |